Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. ReNeuron Group Plc
  6. News
  7. Summary
       

RENEURON GROUP PLC
Delayed London Stock Exchange  - 
- GBX   -.--%
06/14WALL STREET STOCK EXCHANGE : A 0.75% rate hike is getting likelier
06/14ANALYST RECOMMENDATIONS : NetApp, Nike, Oracle, Wizz Air, Walmart...
03/22Reneuron Group plc Announces Directorate Changes
CI
SummaryNewsRatingsCalendarCompany 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about RENEURON GROUP PLC
03/22Reneuron Group plc Announces Directorate Changes
CI
02/11ReNeuron CEO to Step Down at February-End
MT
02/11ReNeuron Group plc Announces CEO Changes, Effective 28 February 2022
CI
02/11ReNeuron Group plc Announces Leaving of Olav Hellebø as Executive Director
CI
02/04TRANSCRIPT : ReNeuron Group plc - Special Call
CI
01/18ReNeuron Down 39% After Out-Licensing Retinitis Pigmentosa Program
MT
01/18ReNeuron Group plc Provides Strategic Update
CI
01/13ReNeuron, Fosun Supplement Stroke Drug Licensing Deal For Potential Technology Transfer
MT
01/13Reneuron Group plc Announces Additional Agreement with Fosun Pharma for CTX
CI
2021RENEURON : Interim Statement 2021
PU
2021TRANSCRIPT : ReNeuron Group plc, H1 2022 Earnings Call, Nov 30, 2021
CI
2021TRANSCRIPT : ReNeuron Group plc, H1 2022 Earnings Call, Nov 30, 2021
CI
2021Earnings Flash (RENE.L) RENEURON GROUP Reports H1 Revenue GBP58,000
MT
2021Earnings Flash (RENE.L) RENEURON GROUP Posts H1 Loss GBX-9.20
MT
2021ReNeuron Group plc Reports Earnings Results for the Half Year Ended September 30, 2021
CI
More most relevant news
All news about RENEURON GROUP PLC
06/14WALL STREET STOCK EXCHANGE : A 0.75% rate hike is getting likelier
06/14ANALYST RECOMMENDATIONS : NetApp, Nike, Oracle, Wizz Air, Walmart...
03/22Reneuron Group plc Announces Directorate Changes
CI
02/11ReNeuron CEO to Step Down at February-End
MT
02/11ReNeuron Group plc Announces CEO Changes, Effective 28 February 2022
CI
02/11ReNeuron Group plc Announces Leaving of Olav Hellebø as Executive Director
CI
02/07Adverum Biotechnologies Names Chief Medical Officer
MT
02/04TRANSCRIPT : ReNeuron Group plc - Special Call
CI
01/18ReNeuron Down 39% After Out-Licensing Retinitis Pigmentosa Program
MT
01/18ReNeuron Group plc Provides Strategic Update
CI
More news
News in other languages on RENEURON GROUP PLC
06/14BOLSA DE MADRID : Los osos son liberados
06/14Les ours sont lâchés
06/14AVIS D'ANALYSTES DU JOUR : LVMH, Kering, Michelin, Scor, Verbund, Swatch, Adidas, Nokia, G..
03/22Reneuron Group plc annonce des changements de direction
02/11Le PDG de ReNeuron se retire à la fin du mois de février
02/11ReNeuron Group plc annonce des changements de PDG, à compter du 28 février 2022
02/11ReNeuron Group plc annonce le départ d'Olav Hellebø ; en tant que directeur exécu..
02/07Adverum Biotechnologies nomme un directeur médical en chef
01/18ReNeuron en baisse de 39 % après l'octroi d'une licence pour son programme sur la rétin..
01/18ReNeuron Group plc présente une mise à jour stratégique
More news
Analyst Recommendations on RENEURON GROUP PLC
06/14ANALYST RECOMMENDATIONS : NetApp, Nike, Oracle, Wizz Air, Walmart...
More recommendations
Press releases
2021RENEURON : Interim Statement 2021
PU
2021RENEURON : New CTX-iPSC platform data shows potential in Peripheral Nerve Repair
PU
2021RENEURON : Collaboration agreement with UCL
PU
2021RENEURON : First subject treated at Oxford Eye Hospital in Phase 2a RP trial
PU
2021RENEURON : Further changes in the Board of Directors
PU
More press releases
Upcoming event on RENEURON GROUP PLC
07/04/22FY 2022 Earnings Call - First Call
Upcoming sector events
07/22/22LONZA GROUP AG : Interim 2022 Earnings Release
07/26/22IQVIA HOLDINGS INC. : Interim 2022 Earnings Release (Projected)
07/28/22SEAGEN INC. : Interim 2022 Earnings Release (Projected)
08/03/22MODERNA, INC. : Interim 2022 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Other Biotechnology & Medical Research